Floodgates open for unproven wellness drugs after US lifts peptide curbs
The US has removed restrictions on peptides, leading to a surge in demand for unproven wellness treatments, especially in anti-ageing and sexual enhancement sectors. Telehealth and beauty companies are capitalizing on this trend, but the lack of rigorous testing raises concerns about safety and efficacy. This shift underscores a broader issue in the regulation of alternative health treatments, highlighting the need for more stringent oversight to ensure consumer safety. For those interested in the full context, the detailed article is available on the Financial Times website.
Original Source
Read the full article at Ft →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.